Intelligent Bio Solutions completes interference study for fingerprint codeine screening system ahead of FDA filing
Reuters2026/08/03 12:32- Intelligent Bio Solutions completed a clinical interference study supporting its FDA 510(k) filing for U.S. clearance to detect codeine.
- Results have not been presented; data analysis is underway with independent verification planned using LC-MS/MS.
- Study indicates common external contaminants on fingertips did not compromise system performance in field-like conditions.
- Work feeds a broader evidence package; the 510(k) submission remains targeted for calendar H2 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Apple Rarely Signs 3-5 Year NAND Long-Term Contracts, May Not Set Price Cap; AI Squeezes Capacity, Shifting Bargaining Power in Storage
Apple is negotiating a 3-5 year long-term NAND flash memory contract with Kioxia, potentially without a price cap. This marks a shift in its procurement strategy from "lower prices and multiple sources" to "volume lock-in and long-term contracts." The change is driven by fierce competition among AI data center clients for storage capacity, forcing Apple to prioritize supply security. Pricing power for storage chips is shifting from buyers to sellers, and the duration of this storage cycle may exceed traditional market expectations.
India Gold price today: Gold rises, according to FXStreet data
The US dollar briefly rebounded to 153.5 against the Japanese yen, down 1.7% in 24 hours.
Silver Price Forecast: XAG/USD jumps to near $37 amid drop in US Dollar, bond yields
Crypto prices
More
